Drug & intervention

letrozole 2.5 MG Oral Tablet [Femara]

RxCUI 153124

What this record represents

SBD · RxNorm

This is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

Related drug records

RxNorm name matches

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.

FemaraBN · CureCurrent ID 23329

letrozole 2.5 MG [Femara]SBDC · CureCurrent ID 34579

letrozole Oral Tablet [Femara]SBDF · CureCurrent ID 30592

{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 21 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 200]BPCK · CureCurrent ID 65483

{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 400]BPCK · CureCurrent ID 65485

{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600]BPCK · CureCurrent ID 65487

Molecular structure

Active ingredient: letrozole

Clinical trials0

Recruiting0

Related conditions0

Synonyms3

Active ingredients and chemical structures

RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.

letrozole RxCUI 72965 · Ingredient View ingredient recordPubChem CID 3902

Conditions being studied

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.